Baxter International (BAX)
Q2 2012 Earnings Call
July 19, 2012 8:30 am ET
Mary Kay Ladone - Vice President of Investor Relations
Robert L. Parkinson - Chairman, Chief Executive Officer and President
Robert J. Hombach - Chief Financial Officer and Corporate Vice President
Norbert G. Riedel - Chief Scientific Officer and Corporate Vice President
David H. Roman - Goldman Sachs Group Inc., Research Division
Michael N. Weinstein - JP Morgan Chase & Co, Research Division
David R. Lewis - Morgan Stanley, Research Division
Rajeev Jashnani - UBS Investment Bank, Research Division
Robert A. Hopkins - BofA Merrill Lynch, Research Division
Lawrence S. Keusch - Raymond James & Associates, Inc., Research Division
Matthew S. Miksic - Piper Jaffray Companies, Research Division
Kristen M. Stewart - Deutsche Bank AG, Research Division
Good morning, ladies and gentlemen, and welcome to Baxter International's Second Quarter Earnings Conference Call. [Operator Instructions] As a reminder, this call is being recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter's permission. If you have any objections, please disconnect at this time.
I would now like to turn the call over to Ms. Mary Kay Ladone, Corporate Vice President, Investor Relations, at Baxter International. Ms. Ladone, you may begin.
Mary Kay Ladone
Thanks, Kevin, and good morning, everyone, and welcome to our Q2 2012 earnings conference call. Joining me today are Bob Parkinson, CEO and Chairman of Baxter International; Bob Hombach, Chief Financial Officer; and Dr. Norbert Riedel, Chief Science and Innovation Officer.